Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.
Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May11 Apr 2014, 10:24 amAmarin Corp. PLC (NASDAQ:AMRN) stock volume was tepid Apr. 10, with just 1,595,690 shares, a third of its three-month average volume of 4,405,235 shares.
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog9 Apr 2014, 11:50 amBiotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns9 Apr 2014, 9:48 amLast week saw a couple of positive FDA panel votes as well as some disappointing data on experimental drugs.
Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines31 Mar 2014, 11:15 pmAdherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines
Amarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules31 Mar 2014, 3:30 pmAmarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules
3 Biotech Stocks Under $10 to Trade for Breakouts28 Mar 2014, 1:08 pmKeep these under-$10 biotech stocks on your radar. Click to view a price quote on ADMP . Click to research the Drugs industry.
Northwest vs Feuerstein rhubarb round 328 Mar 2014, 11:42 amNorthwest Biotherapeutics ( NWBO -9.9% ) takes predictable exception to The Street's Adam Feuerstein regarding his bearish comments after CEO Linda Powers' DC-Vax presentation on March 27. The company insists that the statistical significance of the phase 3 trial results increases its chances of success not decreases as Mr. Feuerstein asserts. It also disputes his opinion that the trial has been ...
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health28 Mar 2014, 10:42 amLONDON, March 28, 2014 /PRNewswire/ -- On Thursday, March 27, 2014, the NASDAQ Composite ended at 4,151.23, down 0.54%, the Dow Jones Industrial Average edged 0.03% lower to 16,264.23, and the S&P 500 closed at 1,849.04, down 0.19%. The losses were broad based with seven out of ten...
Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'21 Mar 2014, 2:22 pmBiotech columnist Adam Feuerstein answers readers' questions about health care companies. Click to view a price quote on AMRN . Click to research the Drugs industry.